These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15535893)

  • 1. [Application of recombinant human activated protein C with blood product administration and deep vein thrombosis in severe sepsis].
    Liu L; Guo FM; Qiu HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Nov; 16(11):643-5. PubMed ID: 15535893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombotic complications of sepsis and their pharmacological prophylaxis].
    Zenáhlíková Z; Výborný J; Uchytil Z; Krska Z; Mazoch J; Malíková I; Kvasnicka J
    Cas Lek Cesk; 2007; 146(7):597-602. PubMed ID: 17722847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C for the treatment of severe sepsis.
    Houston G; Cuthbertson BH
    Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3. Surviving sepsis guidelines campaign].
    Nihon Naika Gakkai Zasshi; 2006 Dec; 95(12):2484-9. PubMed ID: 17240878
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of urosepsis].
    Szabó K
    Orv Hetil; 2008 Jun; 149(23):1095-9. PubMed ID: 18511385
    [No Abstract]   [Full Text] [Related]  

  • 7. The implementation of new therapies for severe sepsis: some questions raised by "early goal-directed therapy, corticosteroid, and recombinant human activated protein c for the treatment of severe sepsis and septic shock in the emergency department".
    Gaieski D; Goyal M
    Acad Emerg Med; 2006 Sep; 13(9):997-9; author reply 999-1000. PubMed ID: 16825672
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
    Kunsdorf-Wnuk A; Marzec-Lewenstein E; Arct-Danielak D; Musioł E; Bohatyrewicz R; Becht R
    Med Sci Monit; 2005 Aug; 11(8):CS49-55. PubMed ID: 16049385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis with Staphylococcus aureus septicemia.
    Prasad R; Mishra OP; Pant P
    Indian Pediatr; 2007 Jan; 44(1):43-5. PubMed ID: 17277432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activated proteine C].
    Montravers P; Quintard H; Piednoir P
    Ann Fr Anesth Reanim; 2006 Mar; 25(3):270-4. PubMed ID: 16387470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to activated protein C in patients with deep vein thrombosis during early puerperium period.
    Ohashi R; Sugimura M; Kawamura T; Tamura N; Kanayama N
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):799-801. PubMed ID: 16026408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjunctive treatment of sepsis].
    Max M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Jan; 41(1):41-2. PubMed ID: 16440261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Exogenous activated protein C in severe sepsis].
    Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
    Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction induced by activated protein C: no role in protection against sepsis?
    Slofstra SH; ten Cate H; Spek CA
    Trends Mol Med; 2006 Aug; 12(8):374-81. PubMed ID: 16820322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant human activated protein C in treatment of severe sepsis in a pregnant patient with fully symptomatic ovarian hyperstimulation syndrome.
    Mikaszewska-Sokolewicz M; Mayzner-Zawadzka E
    Med Sci Monit; 2005 Jun; 11(6):CS27-32. PubMed ID: 15917724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe sepsis in a premature neonate: protein C replacement therapy.
    De Carolis MP; Polimeni V; Papacci P; Lacerenza S; Romagnoli C
    Turk J Pediatr; 2008; 50(4):405-8. PubMed ID: 19014060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep-vein thrombosis in the elderly.
    Piazza G; Seddighzadeh A; Goldhaber SZ
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):393-8. PubMed ID: 18593747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C in a pregnant patient with severe sepsis.
    Mahabeer N; Zwaal J
    Hosp Med; 2005 Feb; 66(2):124. PubMed ID: 15739714
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis.
    ; ; ; ; Bratton SL; Chestnut RM; Ghajar J; McConnell Hammond FF; Harris OA; Hartl R; Manley GT; Nemecek A; Newell DW; Rosenthal G; Schouten J; Shutter L; Timmons SD; Ullman JS; Videtta W; Wilberger JE; Wright DW
    J Neurotrauma; 2007; 24 Suppl 1():S32-6. PubMed ID: 17511543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.